TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Kimberly-Clark has completed its $48.7 billion acquisition of Kenvue, bringing consumer health and beauty names such as Neutrogena, Aveeno, Listerine and Tylenol into the company. The deal expands Kimberly-Clark beyond its established personal care and tissue businesses; financial and operational details beyond the purchase price were not provided in the report.
Kimberly-Clark has completed its $48.7 billion acquisition of Kenvue, bringing a broad range of consumer health and beauty brands under the company that owns Kleenex, Huggies, Andrex and Kotex. The deal expands Kimberly-Clark into beauty and adds Kenvue names including Neutrogena, Aveeno, OGX, Listerine, Tylenol, Benadryl and Nicorette.
The combined portfolio joins Kimberly-Clark’s established household and personal care products with Kenvue’s skin care, hair care, oral care and consumer health businesses. The transaction’s stated value is US$48.7 billion. The source report does not provide further details about the financing, transaction structure or how the purchase price was calculated.
Kimberly-Clark said it will organize operations into four business segments. These include North America; Asia-Pacific-focused markets, covering Greater China, Australia and New Zealand, South Korea and Indonesia; Europe, the Middle East and Africa; and enterprise markets, which include Latin America, India, Southeast Asian markets and Japan. The company did not provide additional information on how the new structure will affect individual products, teams or locations.
Chief Executive Mike Hsu said the company would move quickly to pursue the combination’s potential. Kimberly-Clark also said the enlarged business is positioned to meet demand for “science-backed, high-quality and high-performance solutions across everyday needs.” That is the company’s stated rationale and outlook, rather than a demonstrated result of the acquisition.
A Broader Consumer Care Portfolio
The acquisition gives Kimberly-Clark a presence in product categories beyond its familiar paper goods and personal care lines, including skin care, hair care and over-the-counter health products. The addition of Kenvue’s brands creates a larger mix of everyday consumer products sold across multiple markets. That could broaden the company’s reach with retailers and consumers, although the report gives no projections for sales, cost savings or market share.
For customers, the immediate confirmed change is corporate ownership: Kenvue’s brands now sit within Kimberly-Clark’s business. The completion does not by itself establish whether packaging, product formulas, retail arrangements or brand strategies will change. For investors and employees, the scale of the deal makes execution and integration important questions, but the source report does not specify expected job changes, integration costs or financial targets.
Products Worth Considering
Garmin Forerunner 165 GPS Running Smartwatch, 43 mm, Black
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
Garmin Forerunner 570 GPS Running Smartwatch, 47mm, Aluminum, Black
As an affiliate, we earn on qualifying purchases.
Kenvue’s Path From Johnson & Johnson
Kenvue was spun off from Johnson & Johnson in 2023 and built a portfolio spanning consumer health and beauty. Its brands include Tylenol, Benadryl and Nicorette, as well as Neutrogena, Aveeno, OGX and Listerine. The completed sale transfers that collection of businesses to Kimberly-Clark, which already markets brands such as Kleenex, Huggies, Andrex and Kotex.
Kenvue began a strategic review in July amid falling sales and job cuts, according to the source report. The report does not give the year for that July review or connect any particular review decision directly to the final terms of the acquisition. The sale now ends Kenvue’s status as a standalone company, though details about how its operations will be incorporated were not included.
“Today marks a defining moment in Kimberly-Clark’s 154-year history as we welcome Kenvue and hit the ground running as one company.”
— Mike Hsu, Kimberly-Clark chairman and CEO
Integration Plans Still Undisclosed
The completion is confirmed by the source report, but several practical and financial details remain unclear. It does not state the specific closing date, the transaction’s financing or the expected effect on Kimberly-Clark’s revenue, earnings, debt or cash flow. No post-deal financial forecast or quantified savings target is included.
The source also does not explain whether the brands will retain their existing operating arrangements, whether product portfolios or distribution will change, or whether the companies plan further workforce reductions. Those matters should not be treated as settled based solely on the deal’s completion. Kimberly-Clark’s claims about consumer demand and potential value describe its expectations, not measured outcomes.
Execution Becomes the Next Test
Kimberly-Clark says it will focus on executing the combination and operating through its four stated business segments. Hsu’s comments point to a push for speed, but the source report gives no timetable or specific integration milestones. The next developments to watch are any company disclosures on leadership and organizational arrangements, brand management, financial guidance and the effect of the acquisition on employees and products.
Until those details are provided, the immediate confirmed change is the transfer of Kenvue into Kimberly-Clark’s portfolio. The performance of the enlarged company—and whether it achieves the benefits management expects—will become clearer through later operating updates.
Key Questions
What did Kimberly-Clark acquire?
Kimberly-Clark completed its $48.7 billion acquisition of Kenvue, the consumer health and beauty company spun off from Johnson & Johnson in 2023.
Which brands are now part of Kimberly-Clark?
Kenvue brands joining the portfolio include Neutrogena, Aveeno, OGX, Listerine, Tylenol, Benadryl and Nicorette. Kimberly-Clark already owns brands including Kleenex, Huggies, Andrex and Kotex.
Does the deal mean products or packaging will change?
The source report does not announce changes to products, formulas, packaging or retail availability. It confirms the acquisition’s completion but does not describe consumer-facing changes.
What happens to Kenvue’s business now?
Kimberly-Clark said the combined company will operate through four business segments spanning North America, Asia-Pacific-focused markets, EMEA and enterprise markets. Further details about integration, management and staffing were not provided in the source report.
Source: cosmeticsbusiness.com
